EGFR and mTOR as Therapeutic Targets in Glioblastoma

Oncotarget - United States
doi 10.18632/oncotarget.27094
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Eph Receptors as Therapeutic Targets in Glioblastoma

British Journal of Cancer
Cancer ResearchOncology
2014English

Therapeutic Targets: MTOR and Related Pathways

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

Therapeutic Targets in Malignant Glioblastoma Microenvironment

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2009English

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Frontiers in Oncology
Cancer ResearchOncology
2015English

EphrinB3 and EphrinB4 Receptors Are Potential Therapeutic Targets in Glioblastoma

Canadian Journal of Neurological Sciences
MedicineNeurology
2015English

Bromodomains as Therapeutic Targets

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2011English

EGFR, P53, IDH-1 and MDM2 Immunohistochemical Analysis in Glioblastoma: Therapeutic and Prognostic Correlation

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2015English

Chemokine Receptors as Therapeutic Targets

Japanese Journal of Clinical Immunology
2013English

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy